Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study. 2023

Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
Medical Oncology, Jehangir Clinical Development Center, Pune, India.

The risk factors for breast cancer have been defined in several studies but there is deficient data for specific subtypes. We report here the pathological characteristics of a breast cancer cohort and risk factors for patients with triple-negative disease. In this case-control study, a prospective breast cancer cohort was evaluated for demographic, reproductive, obesity-related and other risk factors using a validated questionnaire. Tumors were characterized for routine pathological characteristics and immunohistochemical markers of basal-like breast cancer. Patients with triple-negative breast cancer (TNBC) constituted cases and those with non-TNBC were controls. Odds ratios (OR) were calculated for each risk factor and independent associations were tested in an unconditional logistic regression analysis. Between 2011 and 2014, 1146 patients were recruited, of whom 912 [TNBC 266 (29.1%), non-TNBC 646 (70.9%)] with sufficient pathology material were analysed. Reproductive factors of parity, breastfeeding, age-at-menarche, age at first full-term pregnancy and oral contraceptive use were not significantly associated with TNBC. Higher body mass index (BMI > 24.9 vs ≤ 24.9, OR 0.89, 95%CI 0.63-1.24, p = 0.49) was not significantly associated while lesser waist circumference (> 80 cm vs ≤ 80 cm, OR 0.64, 95%CI 0.45-0.9, p = 0.012) and lower waist-to-hip ratio were significantly associated (> 0.85 vs ≤ 0.85, OR 0.72, 95%CI 0.51-1.0, p = 0.056), with TNBC. History of tobacco use was not significantly associated while lower socio-economic status was borderline associated with TNBC (socio-economic category > 5 versus ≤ 5, OR 0.73, 95%CI 0.50-1.06, p = 0.106). No factor was significant after adjustment for covariates. Central obesity seems to be preferentially associated with non-TNBC, and lower socio-economic status with TNBC in India, while most other conventional risk factors of breast cancer show no significant association with TNBC versus non-TNBC.

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D064424 Tobacco Use Use of TOBACCO (Nicotiana tabacum L) and TOBACCO PRODUCTS. Tobacco Consumption,Tobacco Chewing,Consumption, Tobacco,Tobacco Uses
D064726 Triple Negative Breast Neoplasms Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN. ER-Negative PR-Negative HER2-Negative Breast Cancer,ER-Negative PR-Negative HER2-Negative Breast Neoplasms,Triple Negative Breast Cancer,Triple-Negative Breast Cancer,Triple-Negative Breast Neoplasm,Breast Cancer, Triple-Negative,Breast Cancers, Triple-Negative,Breast Neoplasm, Triple-Negative,Breast Neoplasms, Triple-Negative,ER Negative PR Negative HER2 Negative Breast Cancer,ER Negative PR Negative HER2 Negative Breast Neoplasms,Triple Negative Breast Neoplasm,Triple-Negative Breast Cancers,Triple-Negative Breast Neoplasms

Related Publications

Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
October 2018, Clinical breast cancer,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 1993, Acta medica portuguesa,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
November 2019, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 1994, European journal of gynaecological oncology,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
December 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 2002, Breast cancer research : BCR,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 1992, Acta oncologica (Stockholm, Sweden),
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 2018, Clinical Medicine Insights. Oncology,
Shona Nag, and Rajesh Dikshit, and Sangeeta Desai, and Anupama Mane, and Sharayu Mhatre, and Rakesh Neve, and Mamta Gurav, and Neelambari Bhosale, and Prema Perumal, and Yogesh Kembhavi, and Dinesh Jethwa, and Rajendra Badwe, and Sudeep Gupta
January 2004, Tumori,
Copied contents to your clipboard!